For clinically significant hypervolemic and euvolemic hyponatremia (serum sodium <125 mEq/L or less marked hyponatremia that is symptomatic and has resisted correction with fluid restriction)
Treatment that can transition from hospital to home
It is imperative that patients discharged from the hospital with the prescription for SAMSCA have timely and reliable fulfillment
SAMSCA (tolvaptan) is selectively distributed through a Specialty Pharmacy Network with a goal of convenient, timely fulfillment
Otsuka America Pharmaceutical, Inc., the distributor of SAMSCA, uses a network of specialty pharmacies to fulfill and retain prescriptions of SAMSCA.
- Otsuka is committed to ensuring that patients have access to the medications they need
SAMSCA is covered nationwide on many Medicaid, Medicare Part D, and commercial plans.*
*Not a guarantee of coverage and reimbursement
Resources for patients continuing
SAMSCA® (tolvaptan) postdischarge
The ideal time to start the discharge planning process is when the clinical decision is made to prescribe SAMSCA for continued use postdischarge. Planning ahead for discharge may help avoid gaps in SAMSCA therapy.